Fund Holdings — Ally Bridge Group (NY) LLC

Total Portfolio Value:
$120.18M
Total Bought:
$66.95M
Total Sold:
$57.78M
Net Transaction:
+$9.17M
Notable People:
Slanix Paul T Alex
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Verona Pharma PlcADS139,067160,701+21,634$8.83M$15.20M12.65%+$6.37M
Soleno Therapeutics Inc120,449178,819+58,370$8.61M$14.98M12.47%+$6.38M
LENZ Therapeutics, Inc.(LENZ)0343,322+343,322$0$10.06M8.37%+$10.06M
Merus N V77,896140,208+62,312$3.28M$7.37M6.14%+$4.10M
Ultragenyx Pharmaceutical InCALL
CALL
01,600+1,600$0$5.82M4.84%+$5.82M
Enliven Therapeutics Inc169,774281,394+111,620$3.34M$5.64M4.70%+$2.30M
ORIC Pharmaceuticals, Inc.(ORIC)0485,629+485,629$0$4.93M4.10%+$4.93M
Replimune Group, Inc.(REPL)0528,491+528,491$0$4.91M4.09%+$4.91M
Tarsus Pharmaceuticals, Inc.(TARS)127,932121,182-6,750$6.57M$4.91M4.08%-$1.66M
Insmed Incorporated(INSM)85,11047,710-37,400$6.49M$4.80M4.00%-$1.69M
Mind Medicine Mindmed Inc390,143726,172+336,029$2.28M$4.71M3.92%+$2.43M
Geron Corporation(GERN)2,056,6373,251,475+1,194,838$3.27M$4.58M3.81%+$1.31M
COMPASS Pathways plcADS(CMPS)01,485,000+1,485,000$0$4.16M3.46%+$4.16M
Centessa Pharmaceuticals PlcADS243,086293,986+50,900$3.50M$3.86M3.21%+$367.4K
Avidity Biosciences Inc0132,744+132,744$0$3.77M3.14%+$3.77M
Solid Biosciences Inc0724,000+724,000$0$3.53M2.93%+$3.53M
Lexeo Therapeutics, Inc.(LXEO)0867,302+867,302$0$3.49M2.90%+$3.49M
Praxis Precision Medicines, Inc.(PRAX)95,58280,880-14,702$3.62M$3.40M2.83%-$218.7K
Tectonic Therapeutic, Inc.(TECX)132,222163,683+31,461$2.34M$3.25M2.71%+$910.7K
Korro Bio, Inc.(KRRO)59,723154,223+94,500$1.04M$1.93M1.60%+$886.5K
Whitehawk Therapeutics, Inc.(WHWK)817,939817,9390$1.46M$1.53M1.27%+$73.6K
Atyr Pharma Inc777,020287,720-489,300$2.35M$1.46M1.21%-$887.9K
Monopar Therapeutics Inc.(MNPR)034,537+34,537$0$1.24M1.03%+$1.24M
Promis Neurosciences Inc1,484,6991,334,428-150,271$1.03M$645.6K0.54%-$387.0K
Axsome Therapeutics, Inc.(AXSM)72,1130-72,113$8.41M$0—-$8.41M
Axsome Therapeutics, Inc.CALL(AXSM)50,0000-50,000$5.83M$0—-$5.83M
Blueprint Medicines Corp74,1920-74,192$6.57M$0—-$6.57M
CG Oncology, Inc.(CGON)132,2980-132,298$3.24M$0—-$3.24M
Context Therapeutics Inc.(CNTX)1,157,4480-1,157,448$708.4K$0—-$708.4K
Dianthus Therapeutics, Inc.(DNTH)80,5840-80,584$1.46M$0—-$1.46M
Edgewise Therapeutics, Inc.(EWTX)102,6500-102,650$2.26M$0—-$2.26M
Edgewise Therapeutics, Inc.CALL(EWTX)100,0000-100,000$2.20M$0—-$2.20M
Janux Therapeutics, Inc.(JANX)81,2920-81,292$2.19M$0—-$2.19M
Springworks Therapeutics Inc281,1390-281,139$12.41M$0—-$12.41M
Trevi Therapeutics, Inc.(TRVI)686,2190-686,219$4.32M$0—-$4.32M
Tyra Biosciences, Inc.(TYRA)107,2440-107,244$997.4K$0—-$997.4K
Xenon Pharmaceuticals Inc.(XENE)69,6030-69,603$2.34M$0—-$2.34M
Page 1 of 1
Ally Bridge Group (NY) LLC — 13F Holdings — Q2 2025 | TickerTrail